|
Summary
May 2010, Vol. 5, No. 3, Pages 345-363
, DOI 10.2217/rme.10.21
(doi:10.2217/rme.10.21)
Research Article Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogrammingH Vaziri, KB Chapman, A Guigova, J Teichroeb, MD Lacher, H Sternberg, I Singec, L Briggs, J Wheeler, J Sampathkumar, R Gonzalez, D Larocca, J Murai, E Snyder, WH Andrews, WD Funk & MD West† † Author for correspondence Aim: To determine whether transcriptional reprogramming is capable of reversing the developmental aging of normal human somatic cells to an embryonic state. Materials & methods: An isogenic system was utilized to facilitate an accurate assessment of the reprogramming of telomere restriction fragment (TRF) length of aged differentiated cells to that of the human embryonic stem (hES) cell line from which they were originally derived. An hES-derived mortal clonal cell strain EN13 was reprogrammed by SOX2, OCT4 and KLF4. The six resulting induced pluripotent stem (iPS) cell lines were surveyed for telomere length, telomerase activity and telomere-related gene expression. In addition, we measured all these parameters in widely-used hES and iPS cell lines and compared the results to those obtained in the six new isogenic iPS cell lines. Results: We observed variable but relatively long TRF lengths in three widely studied hES cell lines (16.09–21.1 kb) but markedly shorter TRF lengths (6.4–12.6 kb) in five similarly widely studied iPS cell lines. Transcriptome analysis comparing these hES and iPS cell lines showed modest variation in a small subset of genes implicated in telomere length regulation. However, iPS cell lines consistently showed reduced levels of telomerase activity compared with hES cell lines. In order to verify these results in an isogenic background, we generated six iPS cell clones from the hES-derived cell line EN13. These iPS cell clones showed initial telomere lengths comparable to the parental EN13 cells, had telomerase activity, expressed embryonic stem cell markers and had a telomere-related transcriptome similar to hES cells. Subsequent culture of five out of six lines generally showed telomere shortening to lengths similar to that observed in the widely distributed iPS lines. However, the clone EH3, with relatively high levels of telomerase activity, progressively increased TRF length over 60 days of serial culture back to that of the parental hES cell line. Conclusion: Prematurely aged (shortened) telomeres appears to be a common feature of iPS cells created by current pluripotency protocols. However, the spontaneous appearance of lines that express sufficient telomerase activity to extend telomere length may allow the reversal of developmental aging in human cells for use in regenerative medicine.
Cited byFang Wang, Yu Yin, Xiaoying Ye, Kai Liu, Haiying Zhu, Lingling Wang, Maria Chiourea, Maja Okuka, Guangzhen Ji, Jiameng Dan, Bingfeng Zuo, Minshu Li, Qian Zhang, Na Liu, Lingyi Chen, Xinghua Pan, Sarantis Gagos, David L Keefe, Lin Liu. (2011) Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell ResearchOnline publication date: 20-Dec-2011. CrossRef Genevieve Gowing, Clive N. Svendsen. (2011) Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives. NeurotherapeuticsOnline publication date: 9-Sep-2011. CrossRef Suneet Agarwal, George Q Daley. (2011) Telomere dynamics in dyskeratosis congenita: the long and the short of iPS. Cell ResearchOnline publication date: 26-Jul-2011. CrossRef Virginia B Mattis, Clive N Svendsen. (2011) Induced pluripotent stem cells: a new revolution for clinical neurology?. The Lancet Neurology 10:4, 383-394 Online publication date: 1-Apr-2011. CrossRef Junjiu Huang, Fang Wang, Maja Okuka, Na Liu, Guangzhen Ji, Xiaoying Ye, Bingfeng Zuo, Minshu Li, Ping Liang, William W Ge, John CM Tsibris, David L Keefe, Lin Liu. (2011) Association of telomere length with authentic pluripotency of ES/iPS cells. Cell ResearchOnline publication date: 1-Feb-2011. CrossRef Anna M. Wobus, Peter Löser. (2011) Present state and future perspectives of using pluripotent stem cells in toxicology research. Archives of ToxicologyOnline publication date: 12-Jan-2011. CrossRef Maria Kokkinaki, Niaz Sahibzada, Nady Golestaneh. (2011) Human iPS-Derived Retinal Pigment Epithelium (RPE) Cells Exhibit Ion Transport, Membrane Potential, Polarized VEGF Secretion and Gene Expression Pattern Similar to Native RPE. STEM CELLSN/A-N/A Online publication date: 1-Jan-2011. CrossRef Rebekah L. Gundry, Paul W. Burridge, Kenneth R. Boheler. (2011) Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. PROTEOMICSn/a-n/a Online publication date: 1-Jan-2011. CrossRef H. Abdulrazzak, D. Moschidou, G. Jones, P. V. Guillot. (2010) Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. Journal of The Royal Society Interface 7:Suppl_6, S689-S706 Online publication date: 6-Dec-2010. CrossRef Anna M. Wobus. (2010) The Janus face of pluripotent stem cells - Connection between pluripotency and tumourigenicity. BioEssays 32:11, 993-1002 Online publication date: 1-Nov-2010. CrossRef Michael D West, Homayoun Vaziri. (2010) Back to immortality: the restoration of embryonic telomere length during induced pluripotency. Regenerative Medicine 5:4, 485-488 Online publication date: 1-Jul-2010. Citation | Full Text | PDF (961 KB) | PDF Plus (962 KB)
|
Reprints & Permissions
Dusko Ilic. (2010) Industry Update: Latest developments in stem cell research and regenerative medicine. Regenerative Medicine 5:4, 607-615 Online publication date: 1-Jul-2010. Citation | Full Text | PDF (461 KB) | PDF Plus (464 KB)
|
Reprints & Permissions
|
|
|